IQV Logo

IQVIA Holdings Inc. (IQV) 

NYSE
Market Cap
$39.87B
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
366 of 776
Rank in Industry
23 of 42

Largest Insider Buys in Sector

IQV Stock Price History Chart

IQV Stock Performance

About IQVIA Holdings Inc.

IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and …

Insider Activity of IQVIA Holdings Inc.

Over the last 12 months, insiders at IQVIA Holdings Inc. have bought $0 and sold $20.2M worth of IQVIA Holdings Inc. stock.

On average, over the past 5 years, insiders at IQVIA Holdings Inc. have bought $5.19M and sold $267.76M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 10,000 shares for transaction amount of $2.73M was made by DANHAKL JOHN G (director) on 2021‑12‑22.

List of Insider Buy and Sell Transactions, IQVIA Holdings Inc.

2024-08-27SaleSee Remarks
1,300
0.0007%
$246.33$320,229-5.56%
2024-03-01SaleSee Remarks
31,678
0.0173%
$250.53$7.94M-7.39%
2024-02-29SaleSee Remarks
14,100
0.0078%
$247.80$3.49M-5.33%
2024-02-28SaleSee Remarks
8,607
0.0047%
$250.17$2.15M-6.50%
2024-02-16SaleSee Remarks
1,000
0.0006%
$241.50$241,500-1.60%
2024-02-16SaleSee Remarks
13,468
0.0075%
$241.10$3.25M-1.60%
2023-12-01SaleSee Remarks
13,117
0.0071%
$214.03$2.81M+6.73%
2023-09-19SaleSee Remarks
27,317
0.0149%
$208.67$5.7M+8.27%
2023-06-05SaleSee Remarks
5,820
0.0031%
$201.89$1.17M+7.35%
2023-05-26SaleSee Remarks
1
<0.0001%
$198.66$199+9.64%
2023-02-16SaleSee Remarks
4,446
0.0024%
$225.61$1M-5.61%
2023-02-16SaleSee Remarks
2,772
0.0015%
$225.57$625,280-5.61%
2023-02-14SaleSee Remarks
1,000
0.0005%
$230.00$230,000-6.88%
2021-12-22Purchasedirector
10,000
0.0052%
$272.93$2.73M-20.82%
2021-11-29Saledirector
555,094
0.2865%
$262.60$145.77M-17.15%
2021-10-25SaleSee Remarks
4
<0.0001%
$256.93$1,028-11.47%
2021-09-23PurchaseSee Remarks
4
<0.0001%
$262.82$1,051-10.85%
2021-08-16SaleSee Remarks
6,055
0.0031%
$250.00$1.51M-5.88%
2021-07-20PurchaseSee Remarks
13
<0.0001%
$245.32$3,189-1.47%
2020-12-23Purchasedirector
63,451
0.0334%
$176.95$11.23M+38.01%

Insider Historical Profitability

6.66%
Bruehlman Ronald ESee Remarks
26224
0.0144%
$219.6931+1.55%
DANHAKL JOHN Gdirector
24344
0.0134%
$219.6928+8.59%
Lo Annie H.director
2062
0.0011%
$219.6910+18.13%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$5.33B11.5621.07M-0.05%-$2.51M0.1
BlackRock$3.89B8.4515.39M+1.48%+$56.6M0.09
Harris Associates$2.57B5.5710.14M+4.06%+$100.02M4.15
State Street$2.01B4.377.96M+0.54%+$10.88M0.08
AllianceBernstein$1.07B2.324.22M-10.85%-$129.93M0.38
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.